To analyze the reason for replacement, revision and overall satisfaction of a cohort who underwent surgical replacement of an inflatable penile prosthesis (IPP). A cohort of 105 patients who underwent IPP replacement from 2005-2007 was retrieved from the prosthesis database. Approximately 21.9% (23) underwent replacement or revision of their prosthesis because of complications, and were further analyzed. Reason for removal was stratified into infectious and non-infectious (erosion, non-function and patient discomfort). Age, race (African American vs nonAfrican American), smoking history, hypertension, diabetes, coronary artery disease and hyperlipidemia were stratified by reason for removal. Finally, we contacted patients and recorded subjective satisfaction with their IPP. The reason for removal was most commonly because of a nonfunctional IPP (47.8%), followed by infection (30.4%), erosion (17.4%) and patient discomfort (4.3%). Age and race did not show a significant difference when analyzing reason for replacement (P40.05). Patients who were smokers (P ¼ 0.907) had hypertension (P ¼ 0.554), diabetes (P ¼ 0.591) or hyperlipidemia (P ¼ 0.219) did not have significantly higher infection rates. Approximately 58.3% were satisfied with their prosthesis, 75% would have the surgery performed again and 91.7% would still recommend prosthesis surgery. Device malfunction was the primary reason for replacement/removal at our institution. Despite the complications of prosthesis reoperation, the majority of patients were still satisfied with their prosthesis, would have the surgery performed again and would recommend prosthesis surgery to a friend.
Introduction
Inflatable penile prosthesis (IPP) implantation remains an effective option for patients who are refractory to other ED treatments. There has been nearly a 40-year evolution in the field of penile implants, yet we are still faced with complications that require the need for surgical intervention. Prosthetic reoperation has been shown to be due to a number of causes, including a malfunctioning device, erosion or infection. 1, 2 The majority of patients who undergo IPP replacement are satisfied with the results and do not require further attention. 3 Surgical re-implantation of IPP devices has been shown to cause greater morbidity and intra-operative complications than initial implantation. 1, 4 However, patient satisfaction after reimplantation and revision has not been well studied.
Several authors have shown that re-implantation surgery has been associated with an increase in infection rates. 5, 6 Complications have also been seen where tissue in-growth into the prosthesis leads to difficulties in explantation. 7 Few IPP series have focused on patient sentiment regarding IPP replacement or revision. The goal of our study was to further evaluate the etiology of initial implant failure, to delineate characteristics associated with initial IPP failure. Additionally, we wanted to evaluate overall patient satisfaction after re-implantation or revision, and finally assess the durability of a replacement IPP.
Materials and methods
After Internal Review Board (IRB) approval, a database of 105 patients who underwent IPP replacement from 2005-2007 was identified. A cohort of 23 (21.9%) replacement or revision IPPs was subselected from the prosthesis database. This included both patients who underwent initial IPP at our institution, as well as those who were referred from other institutions for replacement after a previous explantation. A replacement or revision IPP was defined as a patient who either had a previous IPP explantation or was to undergo removal and replacement at the time of surgery. Reason for removal was stratified into infectious and non-infectious causes (erosion, non-functional and patient discomfort). An infectious cause for removal was documented based on a positive culture at the time of removal. The analysis included demographic information such as age, race (African American vs non-African American) and smoking history, followed by an analysis of co-morbidities, including hypertension, diabetes, coronary artery disease and hyperlipidemia, stratified by reason for removal. Nominal variables were analyzed using the w 2 test. Continuous variables were analyzed using the Mann-Whitney test. All statistical analysis was performed with SPSS 17.0 (IBM, Chicago, IL, USA).
Surgical technique for replacement or revision IPP
Patients were given a minimum of 3 months to heal after their initial explantation. A transverse scrotal incision was made and carried down to the corpora. Upon dilatation of the corpora, if significant fibrosis was present, the cavertomes were used to aid in corporal dilatation. Prior to placement of the cylinders, an antibiotic irrigation was used to soak the device as well as the surgical field. The incision was closed with absorbable suture, and a sterile dressing as well as scrotal support was applied. After a 23-h stay, follow-up was within 2 weeks, and all patients were sent home on 1 week of oral broadspectrum antibiotics.
Patient survey
Patient sentiment was gathered with a five-question survey that assessed patients satisfaction with their prosthesis, overall sexual satisfaction, whether they had erectile function suitable for intercourse, whether they would recommend the initial procedure and whether they would undergo the procedure again. Patients participated in the survey over the phone, and data were collected by a single operator. The patients were given three options to quantify satisfaction (satisfied, indifferent and dissatisfied). Patients also were questioned about their change in ejaculate, libido and orgasm.
Results
Approximately 87% of our cohort was non-African American with a median age of 62 at time of surgery, and only 4.3% of our cohort had a smoking history. Risk factors for replacement included hypertension in 47.8%, diabetes in 30.4%, hyperlipidemia in 13.0% and coronary artery disease in 21.7% (Table 1) . Approximately 47.8% of the replacement cohort had undergone radical prostatectomy. The mean duration of ED prior to initial IPP replacement was 88.3 months.
Age and race did not show a significant difference when analyzing reason for replacement (P40.05). Patients who were smokers (P ¼ 0.907) had hypertension (P ¼ 0.554), diabetes (P ¼ 0.591) or hyperlipidemia (P ¼ 0.219) did not have significantly higher rates of replacement because of infection within our replacement cohort. The reason for removal was most commonly due to a non-functional IPP (47.8%), followed by infection (30.4%), erosion (17.4%) and finally patient discomfort (4.3%). In 82.6% of cases, a three-piece IPP was used for replacement. From our original cohort, three (13.0%) patients had their replacement prosthesis removed since the time of surgery.
Approximately 27.8% of patients reported decreased libido after surgery. Decreased orgasm was reported in 72.2% of patients. The satisfaction rate with regard to the prosthesis itself was 58.3% in our replacement cohort, with 72.7% reporting an erection satisfactory for intercourse. This included 75% of men reporting they would have the procedure performed again and 91.7% would recommend prosthesis surgery to a friend. The overall sexual satisfaction was mixed with 45.5% satisfied as well as 45.5% dissatisfied, with 10% indifferent (Figure 1 ). 
Discussion
This study evaluated the reason for IPP re-implantation at our institution, and subsequent satisfaction rates with a replacement prosthesis. Over one-fifth of our cases (21.9%) during this time period required explantation secondary to postoperative complications. These numbers may be skewed as our institution is a tertiary referral center, especially for revision cases; therefore, they do not represent a complication rate on our first-time IPP surgeries. These cases were made up of patients referred for complications as well as patients who underwent initial placement at our institution. This is similar to previous published complication rates. 8 Minervi et al. looked at 482 implantations and found postoperative complications in 24% of the cases. The complications included minor outcomes, such as penoscrotal hematoma, urinary retention and superficial wound infection. Major complications included mechanical failure (4.4% of total prosthesis implanted), infection (7.7%) and erosion (5.4%). The predominant reason for IPP replacement in our cohort was a non-functional prosthesis (47.8% of reimplantation cases). Infection of the peri-prosthetic area was seen in 7 (30.4%) of our cases. Erosion (17.4%) and patient discomfort (4.3%) were other reasons for IPP replacement. Despite these complications, 75% of our replacement cohort would have the procedure performed again and 91.7% would recommend the procedure to a friend.
The majority of prosthesis in our cohort were three-piece devices, and this could be associated with the high rate of mechanical failure seen in our cohort. This effect does not seem to be manufacturer-dependent, as we had a representative amount of american medical system (AMS) 700CX (11, 48%) and Mentor Titan (6, 26%) models. Two-piece models, such as the Mentor Alpha I (1, 4%) and AMS Ambicor (3, 13%) were also represented. In another retrospective study, Natali et al. compiled 253 implant cases in Europe and found complications in 40 (25.5%) of the cases. 8 The researchers stratified complications on three different AMS models, a three-piece inflatable device (AMS 700CX), a two-piece inflatable device (AMS Ambicor) and a malleable prosthesis (AMS 600-650).
Mechanical failure was seen in a greater percentage of the three-piece model, but patient satisfaction was greater in this model as well. 8 Natali et al.'s experiences are similar to ours, as mechanical failure seems to be the predominant cause of revision surgery. Approximately 47.8% of replacements in our cohort had mechanical failure, and the common causes were auto-inflation and cylinder failure with tubing fracture. Garber et al. looked at 442 cases and found that 5.0% developed device malfunction, with the majority of device failure occurring at 48-59 months. 9 Their study design was to determine the site of mechanical failure, which demonstrated that half of their scrotal implants malfunctioned at the junction where the tubing and the pump strain relief of the Mentor Alpha I meet.
There was a 30% rate of infection in our replacement series. Standard published infection rates vary from 2-7.7% on first-time IPPs, whereas infection rates increase dramatically on replacement IPPs. 1, 5, 10, 11 For example, Jarow showed a first-time IPP replacement infection rate of 1.8% compared with an infection rate of 13.3% in revision surgery.
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In recent literature, revision surgery infectious complications have been noted to be around 5-18%. 6, [12] [13] [14] [15] In the face of infection, the surgeon must remove the prosthesis and in the majority of cases allow adequate time before replacement. Several studies have showed that using an antiseptic washout with an antibiotic-coated IPP significantly reduced infection during revision surgery. 2, 16 Infection may also be related to mechanical failure, as Henry et al. noted that 66% of mechanical failure replacement cases had positive bacterial swab cultures or presence of a biofilm around the prosthesis. 17 Approximately 17.4% of our replacement cohort had erosion of the device that warranted removal. Patients with co-morbidities such as diabetes and vascular disease are more likely to have erosive complications secondary to poor microvascular tissue. 18 Prosthesis wear has been observed mostly at the tip of the distal penile cylinders and the penile pump. 19 It has been hypothesized that the underlying causes of erosion seem to be associated with malfunction, infection or both, suggesting an inflammatory etiology. When stratified on infectious vs non-infectious reasons for removal, we found that co-morbities did not attribute to infectious status (Table 1) .
Overall, 58.3% of our patients who underwent replacement or revision procedures were satisfied with the long-term results of their prosthesis, 75% would have the surgery performed again and 91.7% would recommend prosthesis surgery to a friend (Figure 1 ). Previous studies have reported that the majority of patients are satisfied with their penile implants. 3 However, this study shows that despite Patient discomfort or dissatisfaction is usually seen in patients who are not properly informed of these potential complications prior to the procedure. Tefilli et al. analyzed the psychosexual aspect of IPP replacement and noted that the factors that improved sexual experiences were penile rigidity and how rapid the prosthesis could provide erection. 20 Other complaints of patient dissatisfaction include pain, reduced penile length, cosmetic appearance, insufficient rigidity, altered sensation and difficulties in using the devices. Our study suggests that with proper informed consent, patient satisfaction can be met even in the wake of complications. This is especially important in those patients with multiple co-morbidities.
The study is limited by its retrospective nature and our institution's referral patterns. The questionnaire is limited in that it has not been validated. Despite these limitations, our study shows that complications of IPPs can be managed successfully and maintain a high patient satisfaction.
In conclusion, a non-functional IPP was the primary reason for device replacement at our institution. Patients with high-risk characteristics and co-morbidities are at increased risk for IPP removal/replacement. Despite having a replacement or revision IPP surgery, the majority of patients were ultimately satisfied with their prosthesis and would have the surgery performed again.
